Dr. Richert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5630 Wisconsin Avenue
Apt 606
Bethesda, MD 20815Phone+1 202-288-0872
Education & Training
- National Institutes of healthPost-doc, Myelin Chemistry, Neuroimmunology, 1977 - 1980
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1974 - 1977
- University of Rochester School of Medicine and DentistryClass of 1970
- Cornell UniversityB.S., Zoology, 1966
Certifications & Licensure
- MD State Medical License 1980 - 2025
- DC State Medical License 1981 - 2022
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- AcademicKeys Who's Who in Medical Sciences Education
- Marquis Who's Who in Medicine and Healthcare
- Marquis Who's Who in the World
- Join now to see all
Publications & Presentations
PubMed
- 34 citationsEvaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.Riley Bove, Charles C. White, Gavin Giovannoni, Bonnie I. Glanz, Victor Golubchikov
Neurology(R) Neuroimmunology & Neuroinflammation. 2015-12-01 - 134 citationsConsensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosisCharlotte E. Teunissen, Til Menge, Ayse Altintas, José C. Álvarez-Cermeño, Antonio Bertolotto
Multiple Sclerosis. 2013-05-21 - 51 citationsAntigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain.Rafick Pierre Sekaly, Steven Jacobson, John R. Richert, Cecile Tonnelle, Henry F. McFarland
Proceedings of the National Academy of Sciences of the United States of America. 1988-02-01
Journal Articles
- Serum IL-17F does not predict poor response to IM IFNbeta- 1a in relapsing remitting MS.Bushnell, S.E., Zhao, Z., Stebbins, C.C., Cadavid, D., Buko, A.M., Whalley, E., Davis, J.A., Versage, E., Richert, J., Axtell, R., Steinman, L., Medori, R., Neurology, 1/1/2012
- Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.Fox, R.J. and the CONFIRM Study Investigators, N Eng J Med, 1/1/2012
- Placebo-controlled phase 3study of oral BG-12 for relapsing multiple sclerosis.Gold, R. and the DEFINE Study Investigators, N Eng J Med, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Serum IL-17 levels not confirmed as predictors of non-response to IFN beta in RRMS in a large verification cohort.Bushnell, S., Whalley, E., Zhao, J., Buko, A., Versage, E., Stebbins, C., Davis, J., Cadavid, D., Richert, J., Axtel, R., Steinman, L., Medori, R, Triennial meeting of ECTRIMS/ACTRIMS/ LACTRIMS, Amsterdam, Netherlands, 10/21/2011
- Discovery of serum biomarkers of response to IFN beta-1a in RRMS: Analysis of inflammation proteins.Whalley, E., Zhao, J., Buko, A., Versage, E., Stebbins, C., Davis, J., Cadavid, D., Carulli, J., Richert, J., Medori, R., Bushnell, S., Annual meeting of American Academy of Neurology, Honolulu, HI, 4/13/2011
- Immune regulation in T cells by transcription factor Sp3: Implications for multiple sclerosisSchwechter, A., Grekova, M., Ressom, H., Notario, V., Richert, J, American Assn. of Immunologists Annual Meeting, Boston, MA, 5/14/2006
- Join now to see all
Lectures
- Fast Forward Think Tank on Progressive MSBoston, MA - 12/1/2010
- MS research opportunities in Australia and the need for more MS research funding.Canberra. - 3/17/2009
- 11th Annual BioCEO & Investor Conference.New York - 2/10/2009
- Join now to see all
Other
- Topic: MS.Richert JR, Interviewed by Dr. Frank Adams on "Doctor Radio" (Sirius Radio).
8/24/2010 - Oral therapies for MS.Richert JR, Interviewed on National Public Radio (NPR).
1/20/2010 - New genetics studies in MS.Richert JR, Interviewed on CNN.
7/29/2007 - Join now to see all
Press Mentions
- Marquis Who's Who Recognizes Dr. John R. Richert for Professional Efforts in NeuroscienceMarch 30th, 2017
- Study Adds Evidence That Smoking Worsens MS, and Quitting May HelpJuly 16th, 2009
Grant Support
- Mechanism Of Suppression Of SP3 Gene Expression In MSNational Institute Of Neurological Disorders And Stroke1998–2000
- Human T-Cell Receptor Recognition Of MBPNational Institute Of Neurological Disorders And Stroke1994–1997
- T Cell Recognition Sites On Myelin Basic ProteinNational Institute Of Allergy And Infectious Diseases1994–1995
- Human T Cell Recognition Sites On Myelin Basic ProteinNational Institute Of Allergy And Infectious Diseases1988–1993
- Cloning Of Antigen-Specific T Cells From MS PatientsNational Institute Of Neurological Disorders And Stroke1985–1987
- Reagents To Suppress Autoimmune ResponsesNational Institute Of Neurological Disorders And Stroke1985
- Cloning Of Antigen-Specific T Cells From MS PatientsNational Institute Of Neurological Disorders And Stroke1985
Professional Memberships
- Fellow
- American Neurological AssociationMember
- American Association of ImmunologistsMember
- American Society for Biochemistry & Molecular BiologyMember
- American Society for Experimental NeuroTherapeuticsMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: